Novo Nordisk

fda-approves-wegovy-for-liver-disease-boosting-novo-nordisk-shares

FDA Approves Wegovy for Liver Disease, Boosting Novo Nordisk Shares

Editorial 18 August, 2025

BREAKING NEWS: The FDA has just approved Wegovy for the treatment of a specific...

novo-nordisk-s-weight-loss-drug-offers-hope-for-alzheimer-s-treatment

Novo Nordisk’s Weight-Loss Drug Offers Hope for Alzheimer’s Treatment

Editorial 13 August, 2025

Biogen Inc. CEO Chris Viehbacher has indicated that a successful trial of Novo Nordisk...

novo-nordisk-partners-with-fangzhou-to-tackle-chronic-diseases

Novo Nordisk Partners with Fangzhou to Tackle Chronic Diseases

Editorial 25 July, 2025

Novo Nordisk A/S has announced a strategic partnership with Fangzhou Inc. to address chronic...

novo-nordisk-and-hims-hers-partnership-ends-abruptly

Novo Nordisk and Hims & Hers Partnership Ends Abruptly

Editorial 28 June, 2025

NEW YORK – The unexpected partnership between Novo Nordisk and Hims & Hers, aimed...